Evolent Health provides technology-enabled clinical and administrative services that help U.S. health plans and provider organizations manage high-cost specialty care and complex conditions. Its offerings center on specialty care management, utilization management, care pathways, and related workflows rather than underwriting insurance. Customers typically buy recurring, performance-oriented programs aimed at improving outcomes and controlling medical cost trend in expensive disease categories.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 444.3 | — | -51.1 | — |
| Q3 2025 | 479.5 | — | -26.9 | — |
| Q4 2025 | 468.7 | — | -429.1 | — |
| Q1 2026 | 496.3 | — | -26.6 | — |
| Q2 2026 | 652.5 | 46.9% | -28.4 | — |
All markets — KeepWinning global stock screener
Other companies on NYSE: New America Acquisition I Corp. (NWAX), Gray Media, Inc. (GTN), BlackRock Limited Duration Income Trust (BLW), Costamare Bulkers Holdings Limited (CMDB), Ares Acquisition Corporation III (AAC), Dingdong (Cayman) Limited (DDL)